Company: ALGN
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0001097149-25-000021
Chunk: 112

Company: ALIGN TECHNOLOGY INC
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 112
---
:|:----|---:|:----|:----------------------------------------------------------------------------|:----|--------------------------------------------------------------------------------------------------------------------------------------------:|----------:|:----|:-------|
| Equity compensation plans approved by security holders     |     | $                                                                                           | 1,223,152 |     | -1 |     | $                                                                           |     |                                                                                                                                           $ | 5,406,500 |     | -2),(3 |
| Equity compensation plans not approved by security holders |     | —                                                                                           |           |     |    |     | —                                                                           |     |                                                                                                                                           — |           |     |        |
| Total                                                      |     | $                                                                                           | 1,223,152 |     |    |     | $                                                                           |     |                                                                                                                                   5,406,500 |           |     |        |

(1) Includes 1,018,981 RSUs, 193,143 MSUs at target and 11,028 PSUs which have an exercise price of zero.

(2) Includes 1,875,920 shares available for issuance under our ESPP. We are unable to ascertain with specificity the number of securities to be issued upon exercise of outstanding rights or the weighted average exercise price of outstanding rights under the ESPP.

(3) Includes additional 550,095 of potentially issuable MSUs if performance targets are achieved at maximum payout.

<div align='center'>120</div>

#### COMPANY PROPOSAL 6
<div align='center'>Advisory Vote to Allow Stockholders Owning 25% of our Stock to Call a Special Meeting</div>

We are conducting an advisory vote to gather stockholder perspectives on allowing stockholders holding 25% of our outstanding common stock the right to call a special meeting of stockholders.

#### Overview
Our stockholders do not currently have the right to call a special meeting of stockholders. Our Board recognizes that some stockholders feel that a stockholder right to call a special meeting is an important corporate governance practice. At the same time, our Board believes that special meetings should only be called to discuss critical, time-sensitive issues that cannot wait until our next annual meeting of stockholders and only in cases where a substantial portion of stockholders agree that a special meeting must be called. A failure to receive the support of 25% of stockholders to convene a special meeting is a strong indicator that the issue is unduly narrow and not deemed critical by our stockholders generally.

In considering both this Proposal 6 and Proposal 7, our Board was